-
Thu01Sep2022Fri02Sep2022
-
Mon05Sep2022Wed07Sep2022
-
Sat10Sep2022Tue13Sep2022Rotterdam, The Netherlands
-
Sat10Sep2022Wed14Sep2022Buenos Aires, Argentina
-
Sat10Sep2022Wed14Sep2022
-
Wed21Sep2022Fri23Sep2022
-
Thu29Sep2022Fri30Sep2022
-
Fri30Sep2022Mon03Oct2022
Latest News
Gore acquires InnAVasc Medical
Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease...
Features
History warns us against “optimistic exuberance” in drug-coated balloon trials
The importance of assessing clinical trial data in an objective, balanced way has been borne out by recent history in the vascular surgery space,...
Fistula, graft or catheter—first and foremost, dialysis patients want an access...
“Catheters are not nearly as bad as we make them out to be.” This was one of the salient messages delivered by Theodore Saad...
Videos
Monnie Wasse, past-president of the American Society of Diagnostic and Interventional Nephrology (ASDIN) and director of interventional nephrology at Rush University Medical Centre (Chicago, USA), talks to the next generation about the Nephrology Partnership for Advancing Technology in Healthcare...
